This more collaborative model is being applied to the high-risk innovative early stages of drug discovery, with companies taking on the highly expensive later stage development.

BBC: Falling drug breakthroughs 'a myth'

My risk model starts accumulating a position when the risk is small, and the reward is high and increasing.

FORBES: Huawei Hitting Apple Hard With Fastest Smartphone